| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.9 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
1 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
| mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
1 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
1 |